Product Information
GLYBURIDE-METFORMIN 5-500 MG is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1896 per EA under NDC 57237002501. Its NADAC has been published 652 times since Apr 9, 2014.
FDA first approved this application on Nov 14, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 500 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237002501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077870FDA Approved
11/14/2007
TE Code
AB
On Market Since
11/14/2007
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE-METFORMIN 5-500 MG has been published 652 times since Apr 9, 2014, and over the history we have for it it has risen 134.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1896 per EA |
|---|---|
| All-time high | $0.2013 (Jan 14, 2026) |
| All-time low | $0.0433 (Apr 17, 2024) |
| 52-week high | $0.2013 |
| 52-week low | $0.1804 |
| Median price | $0.0571 |
| Average price | $0.0764 |
| Largest weekly change | +83.1% (Dec 18, 2024) |
| Weeks tracked | 652 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glyburide and Metformin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYBURIDE-METFORMIN 5-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE-METFORMIN 5-500 MG, manufactured by Rising Pharma Holdings Inc., is $0.1896 per EA (NDC 57237002501), effective Sep 30, 2026.
How has the price of GLYBURIDE-METFORMIN 5-500 MG changed over time?
Over the history we have for it, the NADAC for GLYBURIDE-METFORMIN 5-500 MG has risen 134.1%. It has been tracked across 652 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for GLYBURIDE-METFORMIN 5-500 MG?
Since Apr 9, 2014, the NADAC for GLYBURIDE-METFORMIN 5-500 MG has ranged from a low of $0.0433 (Apr 17, 2024) to a high of $0.2013 (Jan 14, 2026), with a median of $0.0571 per EA.
Are there cheaper alternatives to GLYBURIDE-METFORMIN 5-500 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLYBURIDE-METFORMIN 5-500 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYBURIDE-METFORMIN 5-500 MG?
GLYBURIDE-METFORMIN 5-500 MG (NDC 57237002501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.